Mo1762 A Novel Role of GLP-1 Nanomedicine in Amelioration of Gut Inflammation

Anbazhagan, Arivarasu Natarajan; Priyamvada, Shubha; Kumar, Anoop; Gujral, Tarunmeet; Jayawardena, Dulari; Thaqi, Mentor; Mugarza, Edurne; Önyüksel, Hayat; Dudeja, Pradeep K.

doi:10.1016/s0016-5085(14)62378-7

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In obese mice receiving exenatide, a GLP-1 agonist, they also tend to have lower body weight and enhanced sensitivity to sweet taste, compared to those that received vehicle treatment (118). In fact, GLP-1 analogs have also been used as a common anti-inflammatory drug to alleviate complications resulting from type 2 diabetes (51, 95), gut inflammation and inflammatory bowel disease (3,44), as well as cardiovascular diseases (69,80).Hence, activation of taste GPCRs to produce GLP-1 could be a protective mechanism to suppress inflammatory responses.…”

Section: Glp-1: An Anti-inflammatory Agentmentioning

confidence: 99%

Implications of type 1 and type 2 taste receptors on obesity-induced inflammation

Koh¹,

Wang²

2022

Journal of Food Bioactives

View full text Add to dashboard Cite

Obesity is characterized by chronic low-grade inflammation that could lead to the other health complications, such as cardiovascular disease, diabetes, and various cancers. Nutrient intake and dietary preferences are often modulated by taste receptors in the taste buds. Emerging evidence has shown that taste perception is altered during the development of obesity. It is demonstrated that suppression of taste receptor or taste signaling molecules can potentiate inflammatory response, whereas progressive inflammation has shown to attenuate the expression of taste receptors in vivo, which could be suggestive of an interplay between taste signaling and inflammation. This review summarizes the interactions between types 1 and 2 taste receptors and inflammation, as well as the impact of obesity on taste signaling. Taken together, taste receptors might play a crucial role in regulating the inflammatory response during obesity and hence may serve as a potential therapeutic target to prevent the progression of obesity.

show abstract

Section: Glp-1: An Anti-inflammatory Agentmentioning

confidence: 99%